Megestrol acetate v tamoxifen in advanced breast cancer: correlation of hormone receptors and response.

David S. Ettinger(Johns Hopkins University), Bruce W. Dana(Unknown), Philip Bonomi(Rush University Medical Center), Henry P. Browder, Richard H. Creech, Patrick J. Byrne(Cleveland Clinic), Joseph R. Bertino(Rutgers, The State University of New Jersey), Robert B. Catalano, J. Carpenter, Joseph C. Allegra

PubMed

December 1, 1986

Cited by 39

Related Papers

Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

|Journal of the National Comprehensive Cancer Network|2022|1.4k

Determinants of Tumor Response and Survival With Erlotinib in Patients With Non—Small-Cell Lung Cancer

|Journal of Clinical Oncology|2004|1.1k

NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021

|Journal of the National Comprehensive Cancer Network|2021|1k

NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020

|Journal of the National Comprehensive Cancer Network|2019|1k

Non–Small Cell Lung Cancer, Version 4.2024

|Journal of the National Comprehensive Cancer Network|2024|746